From the Food and Drug Administration.
Crawford
Lester M
LM
US Food and Drug Administration, USA.
D000329:Advertising / Q000592:standards*; D004345:Drug Industry / Q000592:standards*; D004347:Drug Interactions; D011464:Epoprostenol / Q000031:analogs & derivatives / Q000627:therapeutic use*; D029001:Herbal Medicine; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D011050:Policy Making; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D011464:Epoprostenol; C427248:treprostinil